XML 82 R72.htm IDEA: XBRL DOCUMENT v3.23.3
Business Segments (Income Statement Information) (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Operating revenues        
Net earned premiums $ 2,406 $ 2,221 [1] $ 7,001 $ 6,435 [1]
Net investment income 553 422 [1] 1,653 1,302 [1]
Non-insurance warranty revenue 407 399 [1] 1,221 1,173 [1]
Other revenues 8 11 [1] 22 24 [1]
Total operating revenues 3,374 3,053 9,897 8,934
Claims, Benefits and Expenses        
Net incurred claims and benefits 1,818 1,873 5,236 4,939
Policyholders’ dividends 8 7 22 20
Amortization of deferred acquisition costs 426 383 [1] 1,208 1,101 [1]
Non-insurance warranty expense 386 371 [1] 1,154 1,092 [1]
Other insurance related expenses 294 297 917 863
Other expenses 78 77 197 222
Total claims, benefits and expenses 3,010 3,008 [1] 8,734 8,237 [1]
Core income (loss) before income tax 364 45 1,163 697
Income tax (expense) benefit on core income (loss) (75) (2) (241) (126)
Core income (loss)  289 43 922 571
Net investment gains (losses) (38) (96) (105) (166)
Income tax (expense) benefit on net investment gains (losses) 7 11 21 38
Net investment gains (losses), after tax (31) (85) (84) (128)
Net income (loss) 258 (42) 838 443
Operating Segments | Specialty        
Operating revenues        
Net earned premiums 829 810 2,438 2,376
Net investment income 136 102 407 305
Non-insurance warranty revenue 407 399 1,221 1,173
Other revenues 0 (1) 0 0
Total operating revenues 1,372 1,310 4,066 3,854
Claims, Benefits and Expenses        
Net incurred claims and benefits 480 459 1,419 1,360
Policyholders’ dividends 2 2 5 5
Amortization of deferred acquisition costs 175 169 508 488
Non-insurance warranty expense 386 371 1,154 1,092
Other insurance related expenses 89 88 269 250
Other expenses 13 15 39 40
Total claims, benefits and expenses 1,145 1,104 3,394 3,235
Core income (loss) before income tax 227 206 672 619
Income tax (expense) benefit on core income (loss) (49) (45) (146) (134)
Core income (loss)  178 161 526 485
Operating Segments | Commercial        
Operating revenues        
Net earned premiums 1,170 1,023 3,336 2,901
Net investment income 156 112 470 343
Non-insurance warranty revenue 0 0 0 0
Other revenues 9 13 22 25
Total operating revenues 1,335 1,148 3,828 3,269
Claims, Benefits and Expenses        
Net incurred claims and benefits 807 733 2,235 1,916
Policyholders’ dividends 6 5 17 15
Amortization of deferred acquisition costs 188 163 532 467
Non-insurance warranty expense 0 0 0 0
Other insurance related expenses 156 145 456 409
Other expenses 11 3 27 21
Total claims, benefits and expenses 1,168 1,049 3,267 2,828
Core income (loss) before income tax 167 99 561 441
Income tax (expense) benefit on core income (loss) (34) (19) (118) (91)
Core income (loss)  133 80 443 350
Operating Segments | International        
Operating revenues        
Net earned premiums 296 270 888 803
Net investment income 26 16 74 44
Non-insurance warranty revenue 0 0 0 0
Other revenues (1) 0 0 0
Total operating revenues 321 286 962 847
Claims, Benefits and Expenses        
Net incurred claims and benefits 178 169 552 487
Policyholders’ dividends 0 0 0 0
Amortization of deferred acquisition costs 63 51 168 146
Non-insurance warranty expense 0 0 0 0
Other insurance related expenses 20 35 102 112
Other expenses 6 11 2 25
Total claims, benefits and expenses 267 266 824 770
Core income (loss) before income tax 54 20 138 77
Income tax (expense) benefit on core income (loss) (14) (1) (36) (14)
Core income (loss)  40 19 102 63
Operating Segments | Life & Group        
Operating revenues        
Net earned premiums 112 118 340 356
Net investment income 216 187 659 600
Non-insurance warranty revenue 0 0 0 0
Other revenues 0 0 0 0
Total operating revenues 328 305 999 956
Claims, Benefits and Expenses        
Net incurred claims and benefits 343 525 998 1,140
Policyholders’ dividends 0 0 0 0
Amortization of deferred acquisition costs 0 0 0 0
Non-insurance warranty expense 0 0 0 0
Other insurance related expenses 29 29 89 89
Other expenses (1) 2 0 7
Total claims, benefits and expenses 371 556 1,087 1,236
Core income (loss) before income tax (43) (251) (88) (280)
Income tax (expense) benefit on core income (loss) 14 59 36 84
Core income (loss)  (29) (192) (52) (196)
Operating Segments | Corporate & Other        
Operating revenues        
Net earned premiums 0 0 0 (1)
Net investment income 19 5 43 10
Non-insurance warranty revenue 0 0 0 0
Other revenues 2 1 7 4
Total operating revenues 21 6 50 13
Claims, Benefits and Expenses        
Net incurred claims and benefits 10 (13) 32 36
Policyholders’ dividends 0 0 0 0
Amortization of deferred acquisition costs 0 0 0 0
Non-insurance warranty expense 0 0 0 0
Other insurance related expenses 1 1 2 4
Other expenses 51 47 136 133
Total claims, benefits and expenses 62 35 170 173
Core income (loss) before income tax (41) (29) (120) (160)
Income tax (expense) benefit on core income (loss) 8 4 23 29
Core income (loss)  (33) (25) (97) (131)
Eliminations        
Operating revenues        
Net earned premiums (1) 0 (1) 0
Net investment income 0 0 0 0
Non-insurance warranty revenue 0 0 0 0
Other revenues (2) (2) (7) (5)
Total operating revenues (3) (2) (8) (5)
Claims, Benefits and Expenses        
Net incurred claims and benefits 0 0 0 0
Policyholders’ dividends 0 0 0 0
Amortization of deferred acquisition costs 0 0 0 0
Non-insurance warranty expense 0 0 0 0
Other insurance related expenses (1) (1) (1) (1)
Other expenses (2) (1) (7) (4)
Total claims, benefits and expenses (3) (2) (8) (5)
Core income (loss) before income tax 0 0 0 0
Income tax (expense) benefit on core income (loss) 0 0 0 0
Core income (loss)  $ 0 $ 0 $ 0 $ 0
[1] As of January 1, 2023, the Company adopted ASU 2018-12, Financial Services-Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts (ASU 2018-12) using the modified retrospective method applied as of the transition date of January 1, 2021. Prior period amounts in the financial statements have been adjusted to reflect application of the new guidance. See Note A to the Condensed Consolidated Financial Statements for additional information.